A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data...

Area of Science:

• Biomarker Discovery
• Molecular Diagnostics
• Genomics

Background:

• MicroRNAs (miRNAs) are increasingly recognized as vital biomarkers for early disease detection.
• Accurate quantification of miRNAs in biological fluids is crucial for clinical applications.
• Pancreatic lesions represent a significant area for biomarker research.

Purpose of the Study:

• To assess the reproducibility of NanoString nCounter™ technology for miRNA abundance analysis.
• To evaluate miRNA quantification in plasma and cystic fluid from patients with pancreatic lesions.
• To identify sources of variability in miRNA measurement across multiple study centers.

Main Methods:

• Multi-center pilot study design with sample triplicates.
• Analysis of RNA isolation, sample processing, hybridization, and lot-to-lot variability.
• Evaluation of positive/negative controls, housekeeping genes, spike-in genes, and miRNA expression using nCounter™ technology.

Main Results:

• High correlation (r>0.9) observed for positive controls across sites.
• Consistent expression patterns and clustering of 55 identified miRNAs after normalization.
• Similar distribution and correlation coefficients for housekeeping and spike-in genes across replicate samples.

Conclusions:

• The NanoString nCounter™ platform demonstrates reproducible miRNA quantification across study sites.
• Implementation of stringent quality control procedures is vital for multi-center miRNA studies.
• This technology shows promise for reliable miRNA biomarker analysis in clinical settings.